You are here: Industry Insights > infections

News List

Professor James Rothman, Nobel Laureate, to Join the Board of Noscendo GmbH Biotech Newswire
August 21, 2024
Noscendo GmbH announced that Professor James Rothman has agreed to serve on its board as an independent director.
A Dark Horse in the Antibiotic World is Coming! Probably the Ultimate Weapon to Snipe Super-strong Bacteria Big Cat of Medical Field
July 03, 2024
On April 5, 2024, a new study from a Swedish university caused a stir in the scientific community.
Top Bulk Griseofulvin Powder Manufacturers in China Recommended PharmaSources.com
April 23, 2021
Description, Specifications and Forms, Manufacturing Process, etc., of Griseofulvin.
Chinese mainland reports 73 new local COVID-19 cases NMPA
February 09, 2022
The Chinese mainland on Tuesday recorded 73 locally transmitted COVID-19 cases.
Evolving World of Pharma: AMR-pushing healthcare back in time Sarah Harding
December 13, 2019
Most of us take for granted the ability to fight infections that, less than a century ago, could have caused severe illness, disfigurement or death.
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections drugs
July 22, 2019
Recarbrio OK'd for Complicated Urinary Tract, Intra-Abdominal Infections.
Merck’s Recarbrio gets FDA approval for treatment of infections pharmaceutical-technology
July 19, 2019
The US Food and Drug Administration (FDA) has approved Merck’s Recarbrio injection for the treatment of complicated urinary tract infections (cUTI) and intra-abdominal infections (cIAI).
FDA Approves Treatment for Complicated Urinary Tract, Complicated Intra-Abdominal Infections americanpharmaceuticalreview
July 19, 2019
The U.S. Food and Drug Administration (FDA) has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).
Gilead to donate 2.4M bottles of Truvada in push to limit HIV infections fiercepharma
May 13, 2019
With HIV rates in the U.S. holding steady, health officials are looking to drugmakers for help containing its spread.
Personalizing viral phages to fight resistant infections fiercebiotech
May 10, 2019
The Howard Hughes Medical Institute and the University of Pittsburgh started a program called SEA-PHAGES in the 1990s that offered college students an opportunity to hunt for bacteria-killing viruses known as bacteriophages.

Previous page 1 2 Next page